Nancy G. Azizian

The University of Texas MD Anderson Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “XPO1-dependent nuclear export as a target for cancer therapy”.

XPO1-dependent nuclear export as a target for cancer therapy

Journal of Hematology & Oncology(2020)10.1186/s13045-020-00903-4

N/A

0DataRank · unranked

244 citations

Yulin Li, Nancy G. Azizian

Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells

BMC Cancer(2021)10.1186/s12885-021-07967-6

N/A

0DataRank · unranked

38 citations

Delaney K. Sullivan, Nancy G. Azizian, Yuanhui Liu, Yulin Li, Rong Du

mTOR inhibition attenuates chemosensitivity through the induction of chemotherapy resistant persisters

Nature Communications(2022)10.1038/s41467-022-34890-6

N/A

0DataRank · unranked

64 citations

Nancy G. Azizian, Delaney K. Sullivan, Yulin Li, Yuanhui Liu

mTOR is a Major Determinant of Chemosensitivity

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.19.476916

N/A

0DataRank · unranked

0 citations

Nancy G. Azizian, Delaney K. Sullivan, Yulin Li, Yuanhui Liu

IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer

npj Precision Oncology(2025)10.1038/s41698-025-01041-1

N/A

0DataRank · unranked

14 citations

Tuyen Bui, Juliana Navarro-Yepes, Sanaz Ghotbaldini, Bethanie Quintela, Catherine K. Luo +19 more